Acumen Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
4.4 | 48.77 | -90.98% | 1.9 | +131.57% |
| P/S |
|
703.62 | 33.77 | 1983.81% |
|
|
| P/BV |
|
0.6737 | 4.83 | -86.05% |
|
|
| P/FCF |
|
-8.45 | 61 | -113.85% |
|
|
| Ev/Ebitda |
|
-2.32 | -22.17 | -89.53% |
|
|
| Ev/S |
|
429.96 | 22.57 | 1804.76% |
|
|
| Ev/FCF |
|
-3.28 | 68.76 | -104.77% |
|
|
| E/P |
|
-0.1439 | 0.0178 | -909.62% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3.8 | 4.97 | -176.47% | 662.41 | -100.57% |
| ROE |
|
-19.62 | 9.61 | -304.09% |
|
|
| ROA |
|
-16.89 | 0.3443 | -5005.33% |
|
|
| ROIC |
|
-96.94 | 7.63 | -1369.79% |
|
|
| ROS |
|
-15918.24 | -25.17 | 63142.62% |
|
|
| ROCE |
|
-22.9 | 15.45 | -248.23% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4627 | -3.68 | -87.41% | -0.298 | +55.25% |
| Nеt Debt/Ebitda |
|
0.63 | -3.44 | -118.33% |
|
|
| Debt/Ratio |
|
0.0909 | 0.1986 | -54.21% |
|
|
| Debt/Equity |
|
170.93 | 1.66 | 10182.19% |
|
|
| Debt/Net Income |
|
-0.5385 | 10.32 | -105.22% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-30 | -57.64 | -47.95% | ||
| Growth impulse Ebitda in 5 years |
|
552.66 | -90.94 | -707.72% | ||
| Growth impulse Net Income in 5 years |
|
554.64 | -97.8 | -667.12% | ||
| Growth impulse FCF in 5 years |
|
515.5 | -108.72 | -574.15% | ||
| Growth impulse EPS in 5 years |
|
299.03 | -142.05 | -310.51% |
IP Score
4.19/10
